286
Views
6
CrossRef citations to date
0
Altmetric
Original Research

In Patients with Mild-to-Moderate COPD, Tobacco Smoking, and Not COPD, Is Associated with a Higher Risk of Cardiovascular Comorbidity

ORCID Icon, , ORCID Icon, ORCID Icon, , , ORCID Icon, , , & show all
Pages 1545-1555 | Published online: 01 Jul 2020

References

  • VogelmeierCF, CrinerGJ, MartinezFJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 Report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP28128970
  • ZielinskiJ, MacNeeW, WedzichaJ, et al. Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch Chest Dis. 1997;52(1):43–47.9151520
  • DivoM, CoteC, de TorresJP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155–161. doi:10.1164/rccm.201201-0034OC22561964
  • FearyJR, RodriguesLC, SmithCJ, HubbardRB, GibsonJE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax. 2010;65(11):956–962. doi:10.1136/thx.2009.12808220871122
  • ChenW, ThomasJ, SadatsafaviM, FitzGeraldJM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(8):631–639. doi:10.1016/S2213-2600(15)00241-626208998
  • GolpeR, Martin-RoblesI, Sanjuan-LopezP, et al. Prevalence of major comorbidities in chronic obstructive pulmonary disease caused by biomass smoke or tobacco. Respiration. 2017;94(1):38–44. doi:10.1159/00047271828456807
  • TriestFJJ, StudnickaM, FranssenFME, et al. Airflow obstruction and cardio-metabolic comorbidities. COPD. 2019;1–9.
  • SalviSS, BarnesPJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374(9691):733–743. doi:10.1016/S0140-6736(09)61303-919716966
  • MathesonMC, BenkeG, RavenJ, et al. Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease. Thorax. 2005;60(8):645–651. doi:10.1136/thx.2004.03517016061705
  • GuillienA, PuyraveauM, SoumagneT, et al. Prevalence and risk factors for COPD in farmers: a cross-sectional controlled study. Eur Respir J. 2015.
  • BolundAC, MillerMR, SigsgaardT, SchlunssenV. The effect of organic dust exposure on long-term change in lung function: a systematic review and meta-analysis. Occup Environ Med. 2017;74(7):531–542. doi:10.1136/oemed-2016-10396328404791
  • SorianoJB, ZielinskiJ, PriceD. Screening for and early detection of chronic obstructive pulmonary disease. Lancet. 2009;374(9691):721–732. doi:10.1016/S0140-6736(09)61290-319716965
  • KaplanA, ThomasM. Screening for COPD: the gap between logic and evidence. Eur Respir Rev. 2017;26:143. doi:10.1183/16000617.0113-2016
  • DeganoB, BouhaddiM, LaplanteJJ, et al. [COPD in dairy farmers: screening, characterization and constitution of a cohort. The BALISTIC study]. Rev Mal Respir. 2012;29(9):1149–1156. doi:10.1016/j.rmr.2012.08.00723200591
  • SoumagneT, GuillienA, RouxP, et al. Quantitative and qualitative evaluation of spirometry for COPD screening in general practice. Respir Med Res. 2019;77:31–36. doi:10.1016/j.resmer.2019.07.00432035336
  • BarreraC, RocchiS, DeganoB, et al. Microbial exposure to dairy farmers’ dwellings and COPD occurrence. Int J Environ Health Res. 2018;1–13.
  • GuillienA, PuyraveauM, SoumagneT, et al. Prevalence and risk factors for COPD in farmers: a cross-sectional controlled study. Eur Respir J. 2016;47(1):95–103. doi:10.1183/13993003.00153-201526453630
  • QuanjerPH, StanojevicS, ColeTJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343. doi:10.1183/09031936.0008031222743675
  • CharlsonME, PompeiP, AlesKL, MacKenzieCR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-83558716
  • StanojevicS, GrahamBL, CooperBG, et al. Official ERS technical standards: global lung function initiative reference values for the carbon monoxide transfer factor for Caucasians. Eur Respir J. 2017;50:3. doi:10.1183/13993003.00010-2017
  • BatyF, PutoraPM, IsenringB, BlumT, BrutscheM. Comorbidities and burden of COPD: a population based case-control study. PLoS One. 2013;8(5):e63285. doi:10.1371/journal.pone.006328523691009
  • LangeP, MogelvangR, MarottJL, VestboJ, JensenJS. Cardiovascular morbidity in COPD: a study of the general population. COPD. 2010;7(1):5–10. doi:10.3109/1541255090349950620214458
  • JohnstonAK, ManninoDM, HaganGW, DavisKJ, KiriVA. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax. 2008;63(7):599–605. doi:10.1136/thx.2007.08811218245145
  • SoumagneT, RocheN, GuillienA, et al. Cardiovascular risk in COPD: deciphering the contribution of tobacco smoking. Chest. 2019.
  • van DoornD, RichardsonN, OsborneA. Farmers have hearts: the prevalence of risk factors for cardiovascular disease among a subgroup of irish livestock farmers. J Agromedicine. 2017;22(3):264–274. doi:10.1080/1059924X.2017.131872828406370
  • Ben KhedherS, NeriM, GuidaF, et al. Occupational exposure to endotoxins and lung cancer risk: results of the ICARE study. Occup Environ Med. 2017;74(9):667–679. doi:10.1136/oemed-2016-10411728490662